Advertisement
 |
  
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Reaction To Viread
Here's a taste of what TheBody.com has to offer on this topic:
Ask the Experts
Resistance to Viread, Envitra??Hi I'm newly diagnosed and recently started treatment as well. My first medication was Atripla, which after one day I had a bad reaction to so I stopped taking it. I returned to my doctor and she put me on Tuvada-Lexiva-Norvir. My question...
Response from Benjamin Young, M.D., Ph.D.
Rocky Mountain CARES
Hello and thank you for your post.It's really unlikely that a single dose of Atripla would have caused resistance to the tenofovir/FTC parts (AKA Truvada). Hence, the regimen of Truvada+ boosted Lexiva should retain full activity. So, be well....
Read more »
Viread and urinary problemsIs it possible, by any stretch of the imagination, that Viread might cause or aggravate... Read more »Viread & Hair LossAbout a year ago, I switched from Combivir and Sustiva to Viread, Epivir and Sustiva. This was to... Read more »
Articles
Expanded Indication for Viread, to Include the Treatment of Patients 12 to Less Than 18 Years of AgeOn March 24, 2010, the FDA approved revised labeling for Viread (tenofovir disproxil fumarate) to expand the indication to include the treatment of HIV HIV infection in combination with other antiretroviral agents in patients 12 to less than 18... Read more »
Viread: New Formulation and Pediatric Dosing UpdateOn January 18, 2012, the Viread (tenofovir disoproxil fumarate) labeling was updated to include dosing information in pediatric patients 2 to less than 18 years of age. An oral powder (40 mg per 1 gram of oral powder) formulation and 150 mg,... Read more »
Gilead Expanding List of Countries Eligible to Receive Viread, Truvada at "No-Profit Price"California-based pharmaceutical company Gilead Sciences on Wednesday announced that it is expanding its list of countries eligible to receive the antiretroviral drug Viread at a "no-profit price" to include 27 more nations, mostly in Latin America... Read more »
U.S. Food and Drug Administration Approves Viread®Foster City, Calif. -- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Viread® (tenofovir disoproxil fumarate) for the treatment of chronic hepatitis B, a... Read more »
Connect With Others
Some drug reactions, I think
Posted by ScotCharles, 1 Reply
Hey guys, long time no parlez,For two years I've been on a regimen of Norvir, Atazanavir (Reyetaz) and Truvada (Viread and Emtriva). Last July I developed tingling in my toes (parathesia) which became painful buring and shooting pains. This March,... Read more » Abacavir,viramune,viread
Posted by Anonymous, 2 Replies
I'm on day 4 of my new combo Abacavir,viramune,viread, epivir and it totally sucks. I feel lousy all of the time. Is this typical when starting this combo? This is my 4th combo since diagnosis...Read more » viread
Posted by Anonymous, 2 Replies
Does anyone have any experience with viread? I hear it's supposed to be great in terms of side effects, but I want to know if anyone went on it either a switch or new reg and noticed increased lipo or new lipo or hair loss?Read more » viread
Posted by Anonymous, 1 Reply
Has anyone switched or is using viread? If so, how long and any adverse side effects? I've had problems with pretty much all nukes except 3tc and wanted to see if this drug was similar?Read more »
Tools
Advertisement Advertisement
Resource Centers
Guides for People With HIV
|
My Health Tracker
Assess Your Risk for HIV
Find Local HIV/AIDS Services
The Body: About The Body | Contact The Body | Content Policy | Content Providers | Advertise With Us | Site Map
Remedy Health Media: About Remedy Health Media | Contact Remedy Health Media | Terms of Use | Privacy Policy
The Body is a service of Remedy Health Media, LLC, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.
